“Attention Shareholders: Don’t Miss Out! Pomerantz Law Firm Reminds You to Take Action on Your Investments”

Investigation on Capri Holdings Limited by Pomerantz LLP New York, NY / ACCESS Newswire / January 26, 2025 Pomerantz LLP is investigating claims on behalf of investors of Capri Holdings Limited(“Capri” or the “Company”) (NYSE:CPRI). Investors who are affected are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. Capri Holdings Limited, the luxury…

Read More

Shareholder Alert: Pomerantz Law Firm Investigates Claims on Behalf of Business and Professional Services

The Cato Corporation Investor Investigation New York, NY / ACCESS Newswire / January 26, 2025 Pomerantz LLP, a leading law firm specializing in securities litigation, has announced that it is investigating claims on behalf of investors of The Cato Corporation (NYSE: CATO). The investigation focuses on potential securities law violations by the Company and its…

Read More

“Shareholder Alert: Pomerantz Law Firm Investigates Claims on Behalf of Business and Professional Services Shareholders”

Investigation on Codere Online Luxembourg, S.A. by Pomerantz LLP New York, NY / ACCESS Newswire / January 26, 2025 Pomerantz LLP, a renowned law firm, has recently announced that they are investigating claims on behalf of investors of Codere Online Luxembourg, S.A. This investigation comes after concerns regarding the company’s financial performance and possible breaches…

Read More

Shareholder Alert: Pomerantz Law Firm Reminds Shareholders with Losses on Their Investments to Contact Them

Pomerantz LLP Investigating Claims Against AstraZeneca PLC New York, NY / ACCESS Newswire / January 26, 2025 Pomerantz LLP, a leading law firm specializing in securities litigation, is currently investigating claims on behalf of investors of AstraZeneca PLC (“AstraZeneca” or the “Company”) (NASDAQ:AZN). It has come to our attention that investors may have suffered losses…

Read More

“Attention Shareholders: Pomerantz Law Firm Investigates Claims on Behalf of Business and Professional Services Industry”

Welcome to the Spyre Therapeutics Investigation Blog! Calling all Investors! Are you an investor of Spyre Therapeutics, Inc. (NASDAQ:SYRE)? If so, you may want to pay attention to this latest development. Pomerantz LLP is currently investigating claims on behalf of investors of Spyre Therapeutics, Inc. If you have any information related to this investigation, please…

Read More

“Attention Shareholders: Pomerantz Law Firm Issues Reminder for LO Stockholders”

New Class Action Lawsuit Filed Against Applied Therapeutics, Inc. NEW YORK CITY, NY / ACCESS Newswire / January 26, 2025 Pomerantz LLP announces that a class action lawsuit has been filed against Applied Therapeutics, Inc. (“Applied Therapeutics” or the “Company”) (NASDAQ:APLT). Investors who have been affected by this are advised to contact Danielle Peyton at…

Read More